Cited by 29Health Systems, Economic Evaluations, Quality of LifeGlobal Public Health Policies and EpidemiologyGlobal Health Care Issues

Using economic evidence to support policy decisions to fund interventions for non-communicable diseases

Open access
Bertram, Melanie, Banatvala, Nick, Kulikov, Alexey, Belausteguigoitia, Itziar, Sandoval, Rosa, Hennis, Anselm, Webb, Douglas, Tarlton, Dudley·2019·BMJ

Abstract

Economic analysis of interventions to reduce non-communicable diseases can encourage countries to increase investment, say Melanie Bertram and colleagues

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj.l1648

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Investment cases have justified investments in a growing number of global health needs, from HIV/AIDS to NCDs.

    “investment cases have justified investments in a growing number of global health needs, from HIV/AIDS to NCDs.7”

    From Advancing progress on tobacco control in low-income and middle-income countries through economic analysis (2024) · cites this paper as [7]

    The Country investment cases section (page unavailable) says investment cases provide evidence to request increased NCD funding and justification for development partners to invest. Our copy does not establish the broader claim that investment cases have justified funding across a growing range of needs, including HIV/AIDS. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 6

  1. [4]World Health Organization Making fair choices on the path to universal health coverage. WHO, 2014. PMC4047814 24940009
  2. [10]Allen LN Financing national non-communicable disease responses. Glob Health Action 2017; 10: 1326687. 10.1080/16549716.2017.1326687 28604238 PMC5496084 · DOI
  3. [11]Hatefi A Allen L Donors, non-communicable diseases and universal health coverage to high-quality healthcare: an opportunity for action on global functions for health. J Epidemiol Community Health 2018; 72: 665- 7.. 10.1136/jech-2018-210605 29784637 · DOI
  4. [15]Tam T Building collaborations to integrate economics into noncommunicable disease action. Rev Panam Salud Publica 2018; 42:e36 10.26633/RPSP.2018.36. PMC6385639 31093065 · DOI
  5. [17]Etienne CF Advancing the economics of noncommunicable diseases in the Americas. Rev Panam Salud Publica 2018; 42: e94 10.26633/RPSP.2018.94 31093122 PMC6386096 · DOI
  6. [20]Bloom DE Chen S McGovern ME The economic burden of noncommunicable diseases and mental health conditions: results for Costa Rica, Jamaica, and Peru. Rev Panam Salud Publica 2018; 42: e18 10.26633/Rpsp.2018.18 31093047 PMC6386108 · DOI

Cited by

Sorted by citations

Authors
Bertram, M., Banatvala, N., Kulikov, A., Belausteguigoitia, I., Sandoval, R., Hennis, A., Webb, D., & Tarlton, D.
Affiliations
  • United Nations (US)
  • World Health Organization Regional Office for the Americas (US)
  • United Nations Development Programme (US)
Corresponding author
Bertram, Melanie
Venue
BMJ
Publisher
BMJ
Published
2019-05-20
Volume
365
Pages
l1648
ISSN
  • 1756-1833 (ISSN-L)
  • 0959-8138
OpenAlex
W2945637162
Cited by
29
References
1
Citations by year
2025: 2 · 2024: 7 · 2023: 3 · 2022: 4 · 2021: 8 · 2020: 4 · 2019: 1
FWCI
5.31
Type
journal article
Language
en
Open access
Locations
  • BMJ (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
World Health Organization
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Social Sciences › Business, Management and Accounting › Organizational Behavior and Human Resource Management › Global Public Health Policies and Epidemiology
  • Health Sciences › Health Professions › General Health Professions › Global Health Care Issues
Keywords
non-communicable diseases, economic evaluation, health policy, health investment, cost-effectiveness, health interventions
MeSH terms
Intersectoral Collaboration, Noncommunicable Diseases, Cost-Benefit Analysis, Health Expenditures, Financial Support, Government Programs, Health Plan Implementation, Humans, Public Health, Public Policy, Global Health, Cost of Illness, Resource Allocation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review